Sanofi
SNYNasdaq
$44.66
↑ +1.0%Jul 17 close · end-of-day
Price
1Y↓ -2.8%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
No screener snapshot for this ticker.
Company profile
Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company has collaboration agreement with GlaxoSmithKline to develop a recombinant Covid-19 vaccine; and research collaboration with Stanford University School of Medicine to advance the understanding of immunology and inflammation.
- CEO
- Paul Hudson
- Sector
- Manufacturing
- Industry
- Pharmaceutical Products
- Employees
- 91,600
- Website
- sanofi.com
Earnings
No reported earnings periods on file.
Financial statements
No annual data.
No quarterly data.
Company news
Jul 20, 2026
Jul 17, 2026
Jul 16, 2026
- 4d agoMerck Snags A First-Of-Its-Kind Approval, And Shares Jumpfinance.yahoo.com
- 4d agoMerck Stock Rises After U.S. Approval for Powerful Cholesterol-Cutting Pillfinance.yahoo.com
- 4d agoDow Jones' Merck Snags A First-Of-Its-Kind Approval, And Jumpsfinance.yahoo.com
- 4d agoKalshi Will Offer Sports-Style Betting on Drug Trial Resultsfinance.yahoo.com
- 4d agoMerck Gets Approval for Powerful Cholesterol-Cutting Pillfinance.yahoo.com
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
No insider transactions in the last 12 months.
No insider transactions on file.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.